Ticker: TCRX
Company: TScan Therapeutics, Inc.
Person: Lynx1 Capital Management LP, owns ten percent - or more - of the company
Transaction date: Dec. 19, 2025
Reporting date: Dec. 23, 2025
Average share price: 0.8994132848375475
Bought 161801.0 shares for 145525.97